Article
IRAK1 is a therapeutic target that drives breast cancer metastasis and resistance to paclitaxel
Nature Communications
(2015)
Publication Date
December 1, 2015
DOI
10.1038/ncomms9746
Citation Information
Zhen Ning Wee, Siti Maryam J. M. Yatim, Vera K Kohlbauer, Min Feng, et al.. "IRAK1 is a therapeutic target that drives breast cancer metastasis and resistance to paclitaxel" Nature Communications Vol. 6 Iss. 1 (2015) p. 8746 - 8746 Available at: http://works.bepress.com/dave-hoon/63/